VivoSeq
Other

Total Shoulder Arthroplasty

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Total Shoulder Arthroplasty is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

69/100

Attrition Rate

28/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed11 · 61%
Terminated4 · 22%
Withdrawn1 · 6%
Recruiting1 · 6%
Not yet recruiting1 · 6%

Clinical Trials

Trial Activity

18 trials

Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients
Recruiting·—·Phase 4·NCT05900427·120 enrolled
Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
Not yet recruiting·UUniversity of Alabama at Birmingham·Phase 3·NCT06902714·60 enrolled
Postoperative Pain Control in Total Shoulder Arthroplasty
Completed·SScripps Clinic·Phase 4·NCT05068960·100 enrolled
SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty
Completed·SSt. Louis University·Phase 4·NCT05919888·60 enrolled
Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Completed·CCorewell Health East·Phase 2/3·NCT02043132·116 enrolled
Liposomal Bupivacaine Versus Non-liposomal Bupivacaine for Total Shoulder Arthroplasty
Completed·UUniversity of Virginia·Phase 3·NCT04974385·80 enrolled
Liposomal Bupivacaine in Total Shoulder Arthroplasty
Completed·HHenry Ford Health System·Phase 4·NCT02570022·57 enrolled
Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty
Completed·JJohns Hopkins University·N/A·NCT02762071·108 enrolled
Analgesic Efficacy of Interscalene Nerve Block Versus Local Infiltration Analgesia Following Total Shoulder Arthroplasty
Completed·MMayo Clinic·Phase 4·NCT02876055·125 enrolled
Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty
Completed·MMayo Clinic·Phase 4·NCT05005260·88 enrolled
Liposomal Bupivacaine (Exparel ® ) Plus 0.5% Bupivacaine HCL Versus 0.5% Bupivacaine HCL for Interscalene Nerve Block (ISB) for Patients Undergoing Total Shoulder Arthroplasty(TSA)
Completed·NNYU Langone Health·Phase 4·NCT03913091·184 enrolled
Exparel for Total Shoulder Arthroplasty
Completed·NNorton Healthcare·Phase 4·NCT04364867·102 enrolled
Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty
Completed·RRush University Medical Center·N/A·NCT02569658·110 enrolled
Pain Management After Total Shoulder Arthroplasty
Terminated·TThe Christ Hospital·Phase 4·NCT03219983·22 enrolled
TXA in Revision Total Shoulder Arthroplasty
Terminated·NNYU Langone Health·Phase 4·NCT04650698·19 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)